title: Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1.
authors.forename: Santiago
authors.initials: S
authors.lastname: Moreno
authors.forename: José L
authors.initials: JL
authors.lastname: Casado
authors.forename: María J
authors.initials: MJ
authors.lastname: Pérez-Elías
authors.forename: Fernando
authors.initials: F
authors.lastname: Dronda
authors.forename: Antonio
authors.initials: A
authors.lastname: Antela
authors.forename: Ana
authors.initials: A
authors.lastname: Moreno
authors.forename: Carolina
authors.initials: C
authors.lastname: Gutiérrez
mesh_terms: D000480:Alkynes; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines; D003521:Cyclopropanes; D020008:Delavirdine / Q000627:therapeutic use; D024921:Drug Resistance, Multiple, Viral; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D019829:Nevirapine / Q000627:therapeutic use; D010078:Oxazines / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
chemical_list: D000480:Alkynes; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; D019829:Nevirapine; D020008:Delavirdine; C098320:efavirenz